These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28499391)

  • 1. Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial.
    Becher C; Laute V; Fickert S; Zinser W; Niemeyer P; John T; Diehl P; Kolombe T; Siebold R; Fay J
    J Orthop Surg Res; 2017 May; 12(1):71. PubMed ID: 28499391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Cell Dose on the Early Magnetic Resonance Morphological Outcomes of Autologous Cell Implantation for Articular Cartilage Defects in the Knee: A Randomized Clinical Trial.
    Niemeyer P; Laute V; John T; Becher C; Diehl P; Kolombe T; Fay J; Siebold R; Niks M; Fickert S; Zinser W
    Am J Sports Med; 2016 Aug; 44(8):2005-14. PubMed ID: 27206690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years.
    Niemeyer P; Laute V; Zinser W; John T; Becher C; Diehl P; Kolombe T; Fay J; Siebold R; Fickert S
    Knee Surg Sports Traumatol Arthrosc; 2020 Apr; 28(4):1130-1143. PubMed ID: 31897548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal cartilage defects in the knee - a randomized controlled trial comparing autologous chondrocyte implantation with arthroscopic debridement.
    Randsborg PH; Brinchmann J; Løken S; Hanvold HA; Aae TF; Årøen A
    BMC Musculoskelet Disord; 2016 Mar; 17():117. PubMed ID: 26956476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial.
    Zaslav K; Cole B; Brewster R; DeBerardino T; Farr J; Fowler P; Nissen C;
    Am J Sports Med; 2009 Jan; 37(1):42-55. PubMed ID: 18927254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous Chondrocyte Implantation with Chondrosphere for Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Armoiry X; Cummins E; Connock M; Metcalfe A; Royle P; Johnston R; Rodrigues J; Waugh N; Mistry H
    Pharmacoeconomics; 2019 Jul; 37(7):879-886. PubMed ID: 30426462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial.
    Mumme M; Barbero A; Miot S; Wixmerten A; Feliciano S; Wolf F; Asnaghi AM; Baumhoer D; Bieri O; Kretzschmar M; Pagenstert G; Haug M; Schaefer DJ; Martin I; Jakob M
    Lancet; 2016 Oct; 388(10055):1985-1994. PubMed ID: 27789021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of CARTIGROW® in patients with articular cartilage defects of the knee joint: a four year prospective studys.
    Pathak S; Chaudhary D; Reddy KR; Acharya KKV; Desai SM
    Int Orthop; 2022 Jun; 46(6):1313-1321. PubMed ID: 35344054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture.
    Saris DB; Vanlauwe J; Victor J; Haspl M; Bohnsack M; Fortems Y; Vandekerckhove B; Almqvist KF; Claes T; Handelberg F; Lagae K; van der Bauwhede J; Vandenneucker H; Yang KG; Jelic M; Verdonk R; Veulemans N; Bellemans J; Luyten FP
    Am J Sports Med; 2008 Feb; 36(2):235-46. PubMed ID: 18202295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of Osteochondral Lesions of the Ankle Joint by Implantation of Autologous Chondrocytes].
    Otaševič T; Vališ P; Rouchal M; Novák J; Repko M; Šprláková A; Krbec M
    Acta Chir Orthop Traumatol Cech; 2016; 83(3):169-74. PubMed ID: 27484074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow Edema in the Knee and Its Influence on Clinical Outcome After Matrix-Based Autologous Chondrocyte Implantation: Results After 3-Year Follow-up.
    Niethammer TR; Valentin S; Gülecyüz MF; Roßbach BP; Ficklscherer A; Pietschmann MF; Müller PE
    Am J Sports Med; 2015 May; 43(5):1172-9. PubMed ID: 25784628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of autologous chondrocyte implantation in study of the treatment of articular repair (STAR) patients with osteochondritis dissecans.
    Cole BJ; DeBerardino T; Brewster R; Farr J; Levine DW; Nissen C; Roaf P; Zaslav K
    Am J Sports Med; 2012 Sep; 40(9):2015-22. PubMed ID: 22822178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence and clinical relevance of graft hypertrophy after matrix-based autologous chondrocyte implantation.
    Pietschmann MF; Niethammer TR; Horng A; Gülecyüz MF; Feist-Pagenstert I; Jansson V; Müller PE
    Am J Sports Med; 2012 Jan; 40(1):68-74. PubMed ID: 22031857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroids for Patellofemoral or Tibiofemoral Defects: A 5-Year Follow-up of a Phase 2, Dose-Confirmation Trial.
    Hoburg A; Niemeyer P; Laute V; Zinser W; John T; Becher C; Izadpanah K; Diehl P; Kolombe T; Fay J; Siebold R; Fickert S
    Orthop J Sports Med; 2022 Jan; 10(1):23259671211053380. PubMed ID: 35071653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint.
    Pestka JM; Bode G; Salzmann G; Südkamp NP; Niemeyer P
    Am J Sports Med; 2012 Feb; 40(2):325-31. PubMed ID: 22056348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.
    Bartlett W; Skinner JA; Gooding CR; Carrington RW; Flanagan AM; Briggs TW; Bentley G
    J Bone Joint Surg Br; 2005 May; 87(5):640-5. PubMed ID: 15855365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: an FDA phase-II prospective, randomized clinical trial after two years.
    Crawford DC; DeBerardino TM; Williams RJ
    J Bone Joint Surg Am; 2012 Jun; 94(11):979-89. PubMed ID: 22637204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial.
    Knutsen G; Engebretsen L; Ludvigsen TC; Drogset JO; Grøntvedt T; Solheim E; Strand T; Roberts S; Isaksen V; Johansen O
    J Bone Joint Surg Am; 2004 Mar; 86(3):455-64. PubMed ID: 14996869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes.
    Gudas R; Kalesinskas RJ; Kimtys V; Stankevicius E; Toliusis V; Bernotavicius G; Smailys A
    Arthroscopy; 2005 Sep; 21(9):1066-75. PubMed ID: 16171631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical feasibility of a novel biphasic osteochondral composite for matrix-associated autologous chondrocyte implantation.
    Chiang H; Liao CJ; Hsieh CH; Shen CY; Huang YY; Jiang CC
    Osteoarthritis Cartilage; 2013 Apr; 21(4):589-98. PubMed ID: 23333470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.